The International Prognostic Score (IPS) has been used in classic Hodgkin lymphoma (cHL) for 25 years. However, analyses have documented suboptimal performance of the IPS among contemporarily treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback